Medisca recalls
Medisca appears in 10 official U.S. recall notices indexed by RecallRadar, most recently on 2025-04-30.
Company names are normalized from agency data (legal suffixes removed), so related firms may appear under separate pages.
Recall summary
| Recall notices | 10 |
|---|---|
| Published | 2014-05-07 to 2025-04-30 |
| By agency | FDA Drug (10) |
| By classification | Class II (8), Class I (2) |
| By status | terminated (9), completed (1) |
| Distribution named in notices | US |
Recalls
- Bimatoprost powder, Bulk Ingredient, a) 5g (NDC 38779-3066-03), b) 1g (NDC 38779-3066-06), c) 1g (NDC 38779-3066-09) drums, Medisca, Platts…
FDA Drug · Class II · 2025-04-30 · Medisca
Reason: CGMP Deviations - Budesonide, USP (Micronized), 500 mg, White to off-white odorless, crystalline powder, Medisca Inc., Plattsburgh, NY, 12901, USA, NDC: 3877…
FDA Drug · Class II · 2024-07-10 · Medisca
Reason: CGMP Deviations and Presence of Particulate Matter: Glass - Estriol, USP (Micronized) 1 g, 5 g, 25 g, 100 g, 2000 g, 1 kg, containers, Packed by Medisca Inc., Plattsburgh, NY 12901, USA
FDA Drug · Class II · 2019-12-25 · Medisca
Reason: Failed Impurities/Degradation Specifications - Aminocaproic Acid, USP (6-Aminohexanoic Acid) active pharmaceutical ingredient, packaged in a) 100 g jar (NDC 38779-0989-05, b) 1 kg jar (N…
FDA Drug · Class II · 2017-09-27 · Medisca
Reason: CGMP Deviations: Product manufactured for Industrial Use but was labeled and distributed for Pharmacy Compounding Use. - ESTRADIOL, USP (Hemihydrate)(Micronized), in a) 100 mg (NDC 38779-0869-07), b) 1 g (NDC 38779-0869-06), c) 5 g (NDC 38779-0869-03), d) 10 g…
FDA Drug · Class II · 2017-04-19 · Medisca
Reason: cGMP Deviations; manufacturer initiated recall of API product after deficiencies noted during a recent FDA inspection - ESTRADIOL, USP Bulk (Hemihydrate), in a) 25 g (NDC 38779-2261-04) and b) 100 g (NDC 38779-2261-05) bottles, Packed by MEDISCA INC. PLATTSBU…
FDA Drug · Class II · 2017-04-19 · Medisca
Reason: cGMP Deviations; manufacturer initiated recall of API product after deficiencies noted during a recent FDA inspection - ESTRONE, USP Bulk, in a) 100 mgs (NDC 38779-0891-05), b) 1 gram (NDC 38779-0891-06), c) 5 grams (NDC 38779-0891-03), d) 25 grams (NDC 38779…
FDA Drug · Class II · 2017-04-19 · Medisca
Reason: cGMP Deviations; manufacturer initiated recall of API product after deficiencies noted during a recent FDA inspection - ESTRIOL, USP (Micronized) Bulk, in a) 5 grams (NDC 38779-0732-03), b) 25 grams (NDC 38779-0732-04) , c) 100 grams (NDC 38779-0732-05), and…
FDA Drug · Class II · 2017-04-19 · Medisca
Reason: cGMP Deviations; manufacturer initiated recall of API product after deficiencies noted during a recent FDA inspection - CITRULLINE (L) in 25 g, 100 g, 500 g and 1 kg plastic bottles, White crystals or crystalline powder, odorless, For Use and distribution in…
FDA Drug · Class I · 2016-02-24 · Medisca
Reason: Labeling: Label Mix-Up: FDA tested samples of API from Medisca, labeled as to contain L-Citrulline, and results revealed no L-Citrulline was present. Levels of N-acetyl-leucine were found instead. - Human Chorionic Gonadotropin, EP (HCG) in 5 mu. 2 mu, and 1 mu packages, For use and distribution in prescription compounding, manufacturin…
FDA Drug · Class I · 2014-05-07 · Medisca
Reason: Labeling: Label Error on Declared Strength; Firm states that erroneous potency information was found on the label.